ResearcherRutgers, The State University of New JerseyNo recent work listed
Itzhak Avital
Matched on OpenAlex author ID A5079228493, A5110158399. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2011: 2 papers · 2012: 2 papers · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 7
- [SURGICAL PALLIATION FOR PANCREATIC CANCER]. Co-author PMID 35734796↗
- Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. Co-author DOI 10.1186/s12885-018-4690-1↗
- Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular i… Co-author DOI 10.1007/s10637-014-0157-7↗
- Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells. Last author DOI 10.1016/j.scr.2012.08.001↗
- Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy. Last author DOI 10.1097/mpa.0b013e318249955a↗
- Regional chemotherapy for pancreatic cancer. Co-author DOI 10.1002/jso.21975↗
- Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial. Last author DOI 10.1186/1745-6215-12-129↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Uri Netz · 1 shared paper, 2022 · strength 0.19
- Ido Ashbell · 1 shared paper, 2022 · strength 0.19
- Udo Rudloff · 3 shared papers, 2012–2018 · strength 0.16
- Paper Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. DOI 10.1186/s12885-018-4690-1↗
- Paper Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfu… DOI 10.1007/s10637-014-0157-7↗
- Paper Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating ce… DOI 10.1016/j.scr.2012.08.001↗
- Dandan Li · 1 shared paper, 2018 · strength 0.08
- John E. Mullinax · 1 shared paper, 2018 · strength 0.08
- Jeremy L. Davis · 2 shared papers, 2011–2012 · strength 0.07
- Nadine Abi‐Jaoudeh · 1 shared paper, 2015 · strength 0.05
- Joal D. Beane · 1 shared paper, 2015 · strength 0.05
- Kshama R. Jaiswal · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.